Life sciences commercialization strategy for pharma and biotech
Herspiegel is a consulting firm helping pharmaceutical and biotech companies navigate asset strategy, clinical development, and market launch. The tech stack—SAS, Stata, Tableau, Power BI, Salesforce Health Cloud—reflects a data-heavy practice centered on evidence synthesis and market analytics. Active hiring across consulting, healthcare, and data roles, combined with projects around patient journey mapping and launch readiness, signals scaling of their core go-to-market advisory business.
Herspiegel advises pharmaceutical and biotech companies on commercial strategy and patient access expansion across the product lifecycle—from early asset evaluation through post-launch optimization. The firm integrates market research, clinical evidence strategy, and launch planning with operational execution. Operating across the United States, Canada, India, and the United Kingdom, the company serves mid-market and enterprise life sciences organizations navigating regulatory approval, pricing, reimbursement, and patient engagement. The consulting-led organization is supported by data analytics, design, finance, and legal functions.
SAS, Stata, Tableau, Power BI, Salesforce Health Cloud, and Adobe Creative Suite. Excel and SharePoint anchor project delivery and collaboration.
Market research, asset strategy, patient journey mapping, launch readiness planning, patient service implementation, and internal process automation—particularly around presentation design and contracting workflows.
Other companies in the same industry, closest in size